Dr Karan Kanhai, MD, PhD, is a physician-scientist and oncology specialist with more than 20 years of international experience in oncology, haematology and rare diseases. He has held senior global medical leadership roles across the pharmaceutical and biotechnology sectors, leading clinical development, regulatory strategy, evidence generation and medical governance across the United States, Europe, the Middle East, North Africa and Asia-Pacific. Currently Chief Medical Officer at SmadMinX Therapeutics, Dr Kanhai also advises pharmaceutical and biotech organisations on portfolio strategy and scientific leadership. Passionate about evidence-based medicine and improving outcomes for patients with complex diseases, he brings extensive expertise in cancer research, clinical development and translating scientific advances into meaningful improvements in patient care.
